BNP in acute coronary syndromes: The heart expresses its suffering

European Heart Journal

Volumn 25, Issue 15, 2004, Pages 1284-1286

  Larsen, Alf Inge ^a   Dickstein, Kenneth ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; MYOGLOBIN; TROPONIN;

ACUTE HEART FAILURE; ANTICOAGULATION; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FUNCTION; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION; SURVIVAL;

HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; RISK ASSESSMENT; RISK FACTORS;

EID: 3442879336     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.06.005     Document Type: Review

References (27)

1. Downie P.F., Talwar S., Squire I.B., et al. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clin. Sci. 97:1999;255-258
2. Gardner R.S., Ozalp F., Murday A.J., et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur. Heart J. 24:2003;1735-1743
3. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 106:2002;2913-2918
4. Bazzino O., Fuselli J.J., Perez de Arenaza D., et al. Relative value of N-Terminal ProBrain Natriuretic Peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST elevation acute coronary syndromes. Eur. Heart J. 25:2004;859-866
5. Braunwald E, Jones RH, Mark DB et al. Diagnosing and managing unstable angina Agency for Health Care Policy and Research. Circulation 90:613-622
6. Almeda F.Q., Hendel R.C., Nathan S., et al. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores. J. Invasive Cardiol. 15:2003;502-506
7. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 109:2004;874-880
8. Lagerqvist B., Husted S., Kontny F., et al. Fast Revascularisation during InStability in Coronary artery disease - II Investigators. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J. Am. Coll. Cardiol. 40:2002;1902-1914
9. Pelter M.M., Adams M.G., Drew B.J. Transient myocardial ischemia is an independent predictor of adverse in-hospital outcomes in patients with acute coronary syndromes treated in the telemetry unit. Heart Lung. 32:2003;71-78
10. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 284:2000;835-842
11. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N. Engl. J. Med. 327:1992;146-150
12. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349:2003;1595-1604
13. Ohman E.M., Armstrong P., Califf R.M., et al. for the GUSTO-IIa Investigators. Risk stratification in acute ischemic syndromes using serum troponin T. J. Am. Coll. Cardiol. SI:1995;148A
14. Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 93:1996;1651-1657
15. Diderholm E., Andren B., Frostfeldt G., et al. Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. Am. Heart J. 143:2002;760-767
16. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 105:2002;1760-1763
17. Braunwald E., Antman E.M., Beasley J.W., et al. American College of Cardiology/American. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002. Circulation. 106:2002;1893-1900
18. Jernberg T., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J. Am. Coll. Cardiol. 42:2003;1909-1916
19. Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J. Am. Coll. Cardiol. 41:2003;1264-1272
20. Galvani M., Ferrini D., Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur. J. Heart Fail. 6:2004;327-333
21. Bertrand M.E., Chair, Simoons M.L., et al. Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 23:2002;1809-1840
22. Brosnan M.J., Clark J.S., Jeffs B., et al. Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension. 33:1999;290-297
23. Braunwald E., Kloner R.A. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation. 66:1982;1146-1149
24. Abbate A., Biondi-Zoccai G.G., Bussani R., et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J. Am. Coll. Cardiol. 41:2003;753-760
25. Steg P.G., Dabbous O.H., Feldman L.J., et al. Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 109:2004;494-499
26. Velazquez E.J., Pfeffer M.A. Acute heart failure complicating acute coronary syndromes: a deadly intersection. Circulation. 109:2004;440-442
27. Wu A.H., Parsons L., Every N.R., et al. Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J. Am. Coll. Cardiol. 40:2002;1389-1394